CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -37.5% | 88,583 | -7.5% | 0.00% | – |
| Q2 2022 | $24,000 | -54.7% | 95,738 | +12.0% | 0.00% | – |
| Q4 2021 | $53,000 | -66.9% | 85,491 | -45.4% | 0.00% | – |
| Q3 2021 | $160,000 | +41.6% | 156,720 | +154.8% | 0.00% | – |
| Q2 2021 | $113,000 | -73.3% | 61,514 | -71.4% | 0.00% | – |
| Q1 2021 | $423,000 | +456.6% | 214,971 | +253.5% | 0.00% | – |
| Q4 2020 | $76,000 | -77.8% | 60,816 | -68.1% | 0.00% | – |
| Q3 2020 | $343,000 | -40.8% | 190,753 | +176.4% | 0.00% | – |
| Q2 2020 | $579,000 | +53.2% | 69,014 | -4.4% | 0.00% | – |
| Q1 2020 | $378,000 | +17.4% | 72,172 | +22.3% | 0.00% | – |
| Q4 2019 | $322,000 | -24.2% | 58,989 | -32.5% | 0.00% | – |
| Q3 2019 | $425,000 | -46.7% | 87,346 | -24.0% | 0.00% | – |
| Q2 2019 | $797,000 | -36.9% | 114,975 | -36.8% | 0.00% | – |
| Q1 2019 | $1,263,000 | -15.2% | 181,797 | -28.7% | 0.00% | – |
| Q4 2018 | $1,490,000 | +84.2% | 255,010 | +138.0% | 0.00% | – |
| Q3 2018 | $809,000 | +179.0% | 107,128 | +86.4% | 0.00% | – |
| Q2 2018 | $290,000 | -10.8% | 57,466 | +7.7% | 0.00% | – |
| Q1 2018 | $325,000 | +48.4% | 53,333 | +72.7% | 0.00% | – |
| Q4 2017 | $219,000 | – | 30,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |